MARC Record from Library of Congress

LEADER: 02145cam a22004694a 4500
001 2006036629
003 DLC
005 20071115083844.0
008 061101s2007 nyua b 001 0 eng
010 $a 2006036629
015 $aGBA747592$2bnb
016 7 $a101291357$2DNLM
016 7 $a013772963$2Uk
020 $a9780789032195 (hard : alk. paper)
020 $a0789032198 (hard : alk. paper)
020 $a9780789032201 (soft : alk. paper)
020 $a0789032201 (soft : alk. paper)
035 $a(OCoLC)ocm75087986
035 $a(OCoLC)75087986
040 $aDNLM/DLC$cDLC$dBAKER$dNLM$dBTCTA$dUKM$dC#P$dYDXCP$dDLC
042 $apcc
050 00 $aRS100$b.V64 2007
060 00 $a2007 I-953
060 10 $aQV 736$bV879p 2007
082 00 $a338.4/76151$222
100 1 $aVogel, Ronald J.
245 10 $aPharmaceutical economics and public policy /$cRonald J. Vogel.
260 $aNew York :$bPharmaceutical Products Press,$cc2007.
300 $axxii, 248 p. :$bill. ;$c23 cm.
440 0 $aPharmaceutical health policy
504 $aIncludes bibliographical references (p. 235-243) and index.
505 0 $aThe public choice model of policymaking -- An overview of the pharmaceutical marketplace -- Government regulation and the food and drug administration -- Patent policies -- The cost structure of the pharmaceutical industry -- The demand for pharmaceuticals -- Government health insurance programs and the demand for pharmaceuticals -- Research and development expenditures -- Sales and marketing expenditures -- Industry profitability -- Mergers and acquisitions -- Looking into the future.
650 0 $aPharmaceutical industry.
650 0 $aPharmaceutical policy.
650 0 $aMedical economics.
650 12 $aEconomics, Pharmaceutical$zUnited States.
650 22 $aCosts and Cost Analysis$zUnited States.
650 22 $aGovernment Regulation$zUnited States.
650 22 $aMarketing of Health Services$xeconomics$zUnited States.
650 22 $aPolicy Making$zUnited States.
650 22 $aPublic Policy$zUnited States.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip074/2006036629.html